Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03862222 · ClinicalTrials.gov registry record
Atlas of Retinal Imaging in Alzheimer's Study
A clinical trial, sponsored by University of Rhode Island.
- Completed
- Registry status
- 165
- Enrollment target
NCT03862222: Completed study, sponsored by University of Rhode Island.
NCT03862222 is a clinical trial that has completed, run by University of Rhode Island. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03862222 has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
The Atlas of Retinal Imaging in Alzheimer's (ARIAS) study is a 5-year study examining the natural history of retinal imaging biomarkers associated with disease risk, disease burden, and disease progression in Alzheimer's disease (AD). The objective of this project is to create a 'gold standard' reference database of structural anatomic and functional imaging of the retina, in order to enable the identification and development of both sensitive and reliable markers of AD risk and/or progression. Our ultimate goal is to develop a new screening protocol that identifies changes related to AD 10-20 years before AD is clinically visible.
Primary Outcome
retinal nerve fiber layer (RNFL) thickness
Interventions
- OTHER Retinal Imaging
- OTHER Pupillometry
- OTHER Contrast Sensitivity
- DIAGNOSTIC_TEST Neuropsychological Evaluation
- GENETIC APOE genotyping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2025-05-31 |
What the finished NCT03862222 record still lists
NCT03862222 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Retinal Imaging is the first listed.
NCT03862222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03862222 about?
NCT03862222 is a clinical study titled "Atlas of Retinal Imaging in Alzheimer's Study". The Atlas of Retinal Imaging in Alzheimer's (ARIAS) study is a 5-year study examining the natural history of retinal imaging biomarkers associated with disease risk, disease burden, and disease progression in Alzheimer's disease (AD). The objective of this project is to create a 'gold standard' refe...
What is the current status of trial NCT03862222?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2019-12-16. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT03862222?
The interventions under investigation include: Retinal Imaging (OTHER), Pupillometry (OTHER), Contrast Sensitivity (OTHER), Neuropsychological Evaluation (DIAGNOSTIC_TEST), APOE genotyping (GENETIC).
Who is sponsoring clinical trial NCT03862222?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI